Status:
COMPLETED
Vascular Function, Fish Protein Hydrolysates and Type 2 Diabetes Mellitus
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease of abnormal carbohydrate metabolism which is related with high morbidity and mortality rates caused by its complications. One of the majo...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
Exclusion
- History of symptomatic coronary artery disease;
- Stroke or other known atherosclerotic disease;
- Cancer;
- HIV positive;
- Alcohol or drug abuse within the past 6 months previous the visit 1;
- use any antioxidant supplementation
Key Trial Info
Start Date :
October 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2018
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03318913
Start Date
October 23 2017
End Date
March 28 2018
Last Update
December 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Rio de Janeiro
Macaé, Rio de Janeiro, Brazil, 27979000